MASLD Research Center retweeted
Strong work Maria Mironova @UCSD_GI fellow
PREVALENCE AND RISK FACTORS ASSOCIATED WITH MASLD AND ADVANCED FIBROSIS AMONG OVERWEIGHT INDIVIDUALS: IMPLICATIONS FOR SCREENING GUIDELINES. ovid.com/10.14309/ajg.000000… @AASLDtweets @UCSDHealth @AmCollegeGastro @AmerGastroAssn @INASL_Liver
MASLD Research Center retweeted
New research - ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial
thelancet.com/journals/langa… @DrLoomba
#MASH #MASLD #LiverTwitter #MedTwitter
MASLD Research Center retweeted
Pleased to share our review on MetALD co-authored with @LuisAntonioDiaz @IsraelsenMads @PoseElisa - such a great pleasure working with them on this piece. @rabataller @QAnstee @AASLDtweets @BavenoCoop @EASLnews @UCSD_GI @Dr_Vijay_Shah @AmerGastroAssn
nature.com/articles/s41575-0…
MASLD Research Center retweeted
Efficacy and safety of zalfermin co-administered with semaglutide in stage 2-4 fibrosis in MASH sciencedirect.com/science/ar… @AASLDtweets @EASLnews @wonglaihung @DrHuangDQ @Rob__Brierley @MASLDResearch @mashtagconf @precisionliver
MASLD Research Center retweeted
Proud that @UCSD_GI is ranked #1 globally in Research & Education in the latest U.S. News rankings powered by Clarivate. Testament to our incredible faculty, trainees, staff & collaborators driving innovation and impact every day.
usnews.com/education/best-gl…
MASLD Research Center retweeted
From AI-powered outreach to advancing maternal health equity, our Improvement Excellence Awards spotlight teams reimagining care—reducing no-shows, improving access, lowering postpartum readmissions and redirecting medical supplies to communities in need. health.ucsd.edu/news/feature…
MASLD Research Center retweeted
‼️Starting soon‼️
In recognition of Global #FattyLiver Day, join us for Liver Q&A webinar sponsored by @LiverCoalition
I will be discussing: Understanding, Identifying & Managing #MASLD and #MASH.
See you soon!
@MASLDResearch @UCSD_GI @AmCollegeGastro @AASLDFoundation
Registration is open for our Liver Q&A Webinar on understanding and managing MASLD/MASH (#fattyliverdisease). Featuring Dr. @MonicaTincopa and a special #GlobalFattyLiverDay panel with experts, public health, community leaders, and patient voices. Register: livercoalition.zoom.us/webin…
MASLD Research Center retweeted
Vitamin E dosing study (VEDS) in pts with metabolic... : Hepatology journals.lww.com/hep/abstrac…
Key take home pts-
1. Vit E 200 IU ⬇️ALT in those with ALT >= 60 in MASLD over 6 months
2. No change in LSM by VCTE over 6 months with Vit E @AASLDtweets @INASL_Liver @HEP_Journal
MASLD Research Center retweeted
Bittersweet moment four our former students and now clinical research coordinators @MASLDResearch leaving and going to medical school! Couldn’t be more proud of them and love being able to play a small role in mentoring future generations of doctors 🙏 @AASLDtweets @pattymaysent
MASLD Research Center retweeted
And just like that…
The time you do a Meet the Professor session on #NITs & therapeutics in #MASLD & #MASH @DDWMeeting with your former fellowship director.
Great session discussing diagnosis, risk stratification & treatment🙌
MASLD Research Center retweeted
1/ New review in @HepCommJournal by @PojsakornDan : The global epidemiology of alcohol-associated liver disease (ALD).
ALD is one of the most preventable causes of liver-related death worldwide — and the burden is set to surge.
A thread on what every clinician should know. 🧵
MASLD Research Center retweeted
The future of hepatology: Preventing liver disease together with the public, scientists and artificial intelligence - JHEP Reports jhep-reports.eu/article/S258…
MASLD Research Center retweeted
Advances in genomic discovery are bringing precision medicine closer to the bedside.
In @AGA_Gastro, we explore the promise and pitfalls of genetics and emerging personalized therapeutics in hepatology.
@AjmeraVeeral, V Chen, R Reddy @AmerGastroAssn
gastrojournal.org/article/S0…
MASLD Research Center retweeted
New! Online now: The many pathways driving liver inflammation in MASH dlvr.it/TRgMBy
MASLD Research Center retweeted
1/6 🧵 In patients with ALD referred for early LT: cardiometabolic risk factors (CMRF) matter. In this multicentre cohort, CMRFs were linked to a lower chance of hepatic recompensation after referral. #LiverTwitter @UCSD_GI @MASLDResearch @AjmeraVeeral @DeepikaDevuniMD
MASLD Research Center retweeted
Our review on RLSE in MASH -Noninvasive surrogate endpoints of adverse outcomes,... : Hepatology journals.lww.com/hep/abstrac… @AASLDtweets @EASLnews @BavenoCoop @APASLnews @INASL_Liver @QAnstee @VWSWong @AparnaGoelMD
MASLD Research Center retweeted
Had a brilliant day as a visiting professor at PGIMER Chandigarh- thanks to @ajay_duseja for hosting me! Really enjoyed the research presentations by fellows & ward rounds followed by evening liver society forum! @drnipunverma @MASLDResearch @AASLDPresident @EASLnews @UCSDHealth
MASLD Research Center retweeted
Great CME hosted by Department of Hepatology, @pgichd.
Insightful discussion on recent advances in MASLD by @DrLoomba
Always inspiring to see the impactful work being led by @ajay_duseja .
As a trainee, grateful for the opportunity to learn from leaders in the field.
@drsuniltaneja @atulsachdeva @drnipunverma @drbabupgi
MASLD Research Center retweeted
A new international consensus published in @AGA_Gastro establishes a unified framework for diagnosing and staging liver disease in α-1 antitrypsin deficiency.
Read more here: ow.ly/hl9350Yn4OZ
@DrLoomba @MattiasMandorf1 @AleksanderKrag @PaulYKwo
MASLD Research Center retweeted
Congratulations @f_tavaglione at @MASLDResearch @UCSD_GI for a fantastic paper- great to collaborate with @hanneshgstrm @EASLnews @AASLDtweets @AASLDPresident @AmerGastroAssn @AGA_Gastro
health.ucsd.edu/news/press-r…


























